Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.8289
H.R.8289: Banning Misleading Drug Ads Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced July 5, 2022
- Latest Major Action July 5, 2022
Bill Sponsor
Bill Cosponsors
5 (All Democrats)
Bill Version
- Introduced in House - July 5, 2022
Bill Summary
Banning Misleading Drug Ads Act of 2022 This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| July 5, 2022 |
Referred to the House Committee on Energy and Commerce.
|
| July 5, 2022 |
Introduced in the House by Abigail Spanberger (D-Va.) |